Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $382.51 million. The enterprise value is $132.79 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CTKB has 126.66 million shares outstanding. The number of shares has decreased by -3.11% in one year.
| Current Share Class | 126.66M |
| Shares Outstanding | 126.66M |
| Shares Change (YoY) | -3.11% |
| Shares Change (QoQ) | -0.57% |
| Owned by Insiders (%) | 9.11% |
| Owned by Institutions (%) | 54.95% |
| Float | 109.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.99 |
| Forward PS | 1.68 |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.11 |
| P/FCF Ratio | 21.87 |
| P/OCF Ratio | 17.96 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 7.59 |
Financial Position
The company has a current ratio of 5.62, with a Debt / Equity ratio of 0.04.
| Current Ratio | 5.62 |
| Quick Ratio | 4.74 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.91 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.91% and return on invested capital (ROIC) is -4.26%.
| Return on Equity (ROE) | -2.91% |
| Return on Assets (ROA) | -3.51% |
| Return on Invested Capital (ROIC) | -4.26% |
| Return on Capital Employed (ROCE) | -6.60% |
| Revenue Per Employee | $304,090 |
| Profits Per Employee | -$17,366 |
| Employee Count | 648 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.77 |
Taxes
In the past 12 months, CTKB has paid $3.28 million in taxes.
| Income Tax | 3.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.06% in the last 52 weeks. The beta is 1.42, so CTKB's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -52.06% |
| 50-Day Moving Average | 3.91 |
| 200-Day Moving Average | 5.30 |
| Relative Strength Index (RSI) | 30.44 |
| Average Volume (20 Days) | 688,966 |
Short Selling Information
The latest short interest is 4.19 million, so 3.31% of the outstanding shares have been sold short.
| Short Interest | 4.19M |
| Short Previous Month | 4.14M |
| Short % of Shares Out | 3.31% |
| Short % of Float | 3.84% |
| Short Ratio (days to cover) | 4.26 |
Income Statement
In the last 12 months, CTKB had revenue of $197.05 million and -$11.25 million in losses. Loss per share was -$0.09.
| Revenue | 197.05M |
| Gross Profit | 108.25M |
| Operating Income | -27.36M |
| Pretax Income | -16.25M |
| Net Income | -11.25M |
| EBITDA | -19.98M |
| EBIT | -27.36M |
| Loss Per Share | -$0.09 |
Full Income StatementBalance Sheet
The company has $265.61 million in cash and $15.90 million in debt, giving a net cash position of $249.72 million or $1.97 per share.
| Cash & Cash Equivalents | 265.61M |
| Total Debt | 15.90M |
| Net Cash | 249.72M |
| Net Cash Per Share | $1.97 |
| Equity (Book Value) | 379.62M |
| Book Value Per Share | 2.98 |
| Working Capital | 312.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $21.30 million and capital expenditures -$3.81 million, giving a free cash flow of $17.49 million.
| Operating Cash Flow | 21.30M |
| Capital Expenditures | -3.81M |
| Free Cash Flow | 17.49M |
| FCF Per Share | $0.14 |
Full Cash Flow StatementMargins
Gross margin is 54.94%, with operating and profit margins of -13.89% and -5.71%.
| Gross Margin | 54.94% |
| Operating Margin | -13.89% |
| Pretax Margin | -4.05% |
| Profit Margin | -5.71% |
| EBITDA Margin | -10.14% |
| EBIT Margin | -13.89% |
| FCF Margin | 8.88% |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.11% |
| Shareholder Yield | 3.11% |
| Earnings Yield | -2.94% |
| FCF Yield | 4.57% |
Analyst Forecast
The average price target for CTKB is $5.67, which is 87.75% higher than the current price. The consensus rating is "Hold".
| Price Target | $5.67 |
| Price Target Difference | 87.75% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 5.2 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.2 |
| Piotroski F-Score | 4 |